Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Chicago, Illinois

Chicago, Illinois, United StatesNot linked to an institution yet

0running trials
4closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

No running trial is registered here.

Researchers

No researcher is linked here yet.

Closed trials

Completed
A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia
NCT05227703· Phase 2· Source
Completed
Open-label Trial in Parkinson's Disease (PD)
NCT04760769· Phase 3· Source
Completed
Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)
NCT04542499· Phase 3· Source
Completed
Fixed-Dose Trial in Early Parkinson's Disease (PD)
NCT04201093· Phase 3· Source

Site data: ClinicalTrials.govUpdated 5 Nov 2026

Report an error

Under construction, not live – Chicago, Illinois: trial site – Frontlight Research